Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Immunogenicity, Tolerability, and Safety of BA.1-Adapted BNT162b2 Vaccine in 18- to 55-Year-Olds Previously Vaccinated with BNT162b2 or Who Were COVID-19 Vaccine-Naive
Saved in:
| Published in: | Infectious Diseases and Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1871837991772618752 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Infectious Diseases and Therapy |
| description | |
| discipline_display | Communicable Diseases, Epidemiology |
| discipline_facet | Communicable Diseases, Epidemiology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:106991 |
| institution | FRELIP |
| journal_source_facet | Infectious Diseases and Therapy |
| last_indexed | 2026-07-27T03:43:37.199Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Immunogenicity, Tolerability, and Safety of BA.1-Adapted BNT162b2 Vaccine in 18- to 55-Year-Olds Previously Vaccinated with BNT162b2 or Who Were COVID-19 Vaccine-Naive Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| subject_facet | Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| title | Immunogenicity, Tolerability, and Safety of BA.1-Adapted BNT162b2 Vaccine in 18- to 55-Year-Olds Previously Vaccinated with BNT162b2 or Who Were COVID-19 Vaccine-Naive |
| title_alt | Inmunogenicidad, tolerabilidad y seguridad de la vacuna BNT162b2 adaptada a BA.1 en personas de 18 a 55 años previamente vacunadas con BNT162b2 o sin vacunar contra la COVID-19 Immunogénicité, tolérabilité et sécurité du vaccin BNT162b2 adapté à BA.1 chez les 18-55 ans précédemment vaccinés avec BNT162b2 ou naïfs de vaccin COVID-19 Imunogenicidade, Tolerabilidade e Segurança da Vacina BNT162b2 Adaptada à BA.1 em Indivíduos de 18 a 55 Anos Previamente Vacinados com BNT162b2 ou Sem Vacinação Prévia para COVID-19 |
| title_auth | Immunogenicity, Tolerability, and Safety of BA.1-Adapted BNT162b2 Vaccine in 18- to 55-Year-Olds Previously Vaccinated with BNT162b2 or Who Were COVID-19 Vaccine-Naive |
| title_es_txt | Inmunogenicidad, tolerabilidad y seguridad de la vacuna BNT162b2 adaptada a BA.1 en personas de 18 a 55 años previamente vacunadas con BNT162b2 o sin vacunar contra la COVID-19 |
| title_fr_txt | Immunogénicité, tolérabilité et sécurité du vaccin BNT162b2 adapté à BA.1 chez les 18-55 ans précédemment vaccinés avec BNT162b2 ou naïfs de vaccin COVID-19 |
| title_full | Immunogenicity, Tolerability, and Safety of BA.1-Adapted BNT162b2 Vaccine in 18- to 55-Year-Olds Previously Vaccinated with BNT162b2 or Who Were COVID-19 Vaccine-Naive |
| title_fullStr | Immunogenicity, Tolerability, and Safety of BA.1-Adapted BNT162b2 Vaccine in 18- to 55-Year-Olds Previously Vaccinated with BNT162b2 or Who Were COVID-19 Vaccine-Naive |
| title_full_unstemmed | Immunogenicity, Tolerability, and Safety of BA.1-Adapted BNT162b2 Vaccine in 18- to 55-Year-Olds Previously Vaccinated with BNT162b2 or Who Were COVID-19 Vaccine-Naive |
| title_pt_txt | Imunogenicidade, Tolerabilidade e Segurança da Vacina BNT162b2 Adaptada à BA.1 em Indivíduos de 18 a 55 Anos Previamente Vacinados com BNT162b2 ou Sem Vacinação Prévia para COVID-19 |
| title_short | Immunogenicity, Tolerability, and Safety of BA.1-Adapted BNT162b2 Vaccine in 18- to 55-Year-Olds Previously Vaccinated with BNT162b2 or Who Were COVID-19 Vaccine-Naive |
| title_sort | immunogenicity, tolerability, and safety of ba.1-adapted bnt162b2 vaccine in 18- to 55-year-olds previously vaccinated with bnt162b2 or who were covid-19 vaccine-naive |
| topic | Communicable Diseases, Epidemiology General Communicable Diseases, Epidemiology |
| url | https://link.springer.com/article/10.1007/s40121-026-01409-1 |